Pressure BioSciences’ Partner Veterans Service Team Increases Existing Purchase Order by 10X for Bottles of UltraShear Nano-CBD Topical Spray, Effecti…

MMP News AuthorSeptember 22, 2023
PBIO Acknowledges Rapidly Emerging Demand Potential for UltraShear Nanoemulsions for Transformation of Diverse Major Markets, with Recently Announced Readiness and Scaling Plans SOUTH EASTON, MA / ACCCESSWIRE / September 22, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBIO” or “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, ... Read More

Lexaria’s Groundbreaking Research into DehydraTECH-CBD Published in International Journal of Molecular Science

MMP News AuthorJune 23, 2023
DehydraTECH-CBD now featured in eight published, peer-reviewed papers KELOWNA, BC / ACCESSWIRE / June 22, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces that its groundbreaking research utilizing DehydraTECH-processed cannabidiol (“DehydraTECH-CBD”) has now been published in eight peer-reviewed articles in ... Read More

Lexaria Discovers that DehydraTECH-CBD Treatment in Hypertension Study HYPER-H21-4 Resulted in Reduction in Pro-Inflammatory Biomarkers

MMP News AuthorMay 24, 2023
DehydraTECH-CBD offers distinctive mechanistic benefits related to its growing therapeutic utility KELOWNA, BC / ACCESSWIRE / May 23, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to announce additional findings from last year’s human clinical study HYPER-H21-4 (“the Study”) ... Read More